Prime Medicine, Inc. — All Filings
279 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| EFFECT | — | 9999999995-26-000723 | Mar 4, 2026 | — |
| S-8 | S-8 | 0001628280-26-013575 | Mar 3, 2026 | — |
| 10-K | 10-K | 0001628280-26-013569 | Mar 3, 2026 | Dec 31, 2025 |
| POSASR | POSASR | 0001894562-26-000007 | Mar 3, 2026 | — |
| POS AM | POS AM | 0001894562-26-000009 | Mar 3, 2026 | — |
| 8-K | 8-K | 0001628280-26-013565 | Mar 3, 2026 | — |
| 4 | FORM 4 | 0001628280-26-012893 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | FORM 4 | 0001628280-26-011208 | Feb 24, 2026 | Feb 23, 2026 |
| 4 | FORM 4 | 0001628280-26-011181 | Feb 24, 2026 | Feb 23, 2026 |
| SCHEDULE 13G/A | — | 0001897612-26-000293 | Feb 17, 2026 | — |
| 8-K | 8-K | 0001628280-26-001773 | Jan 12, 2026 | — |
| SCHEDULE 13G | — | 0001897612-25-000555 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001845041-25-000005 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-050422 | Nov 7, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001628280-25-050415 | Nov 7, 2025 | — |
| S-3ASR | S-3ASR | 0001628280-25-050428 | Nov 7, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002807 | Nov 5, 2025 | — |
| 8-K | 8-K | 0001894562-25-000056 | Sep 8, 2025 | — |
| SCHEDULE 13D/A | — | 0001072613-25-000536 | Aug 11, 2025 | — |
| 8-K | 8-K | 0001628280-25-038617 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-038619 | Aug 7, 2025 | Jun 30, 2025 |
| 4 | FORM 4 | 0001894562-25-000043 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001894562-25-000044 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001894562-25-000045 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001894562-25-000046 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001894562-25-000047 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001894562-25-000049 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001894562-25-000048 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001894562-25-000050 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001894562-25-000042 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001894562-25-000051 | Aug 5, 2025 | Aug 1, 2025 |
| 8-K | 8-K | 0001628280-25-037840 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013462 | Aug 1, 2025 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013460 | Aug 1, 2025 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013461 | Aug 1, 2025 | — |
| 424B5 | 424B5 | 0001628280-25-037072 | Jul 31, 2025 | — |
| 8-K | 8-K | 0001628280-25-037076 | Jul 31, 2025 | Jul 30, 2025 |
| 424B5 | 424B5 | 0001628280-25-036721 | Jul 30, 2025 | — |
| 8-K | 8-K | 0001628280-25-036705 | Jul 30, 2025 | — |
| 8-K | 8-K | 0001628280-25-034971 | Jul 15, 2025 | Jul 14, 2025 |
| DEF 14A | DEF 14A | 0001193125-25-158716 | Jul 14, 2025 | Aug 1, 2025 |
| PRE 14A | PRE 14A | 0001193125-25-155000 | Jul 2, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001628280-25-033754 | Jul 1, 2025 | Jun 30, 2025 |
| 4 | FORM 4 | 0001628280-25-032626 | Jun 23, 2025 | — |
| 4 | FORM 4 | 0001628280-25-031637 | Jun 16, 2025 | — |
| 4 | FORM 4 | 0001628280-25-031045 | Jun 12, 2025 | Jun 11, 2025 |
| 4 | FORM 4 | 0001628280-25-029771 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001628280-25-029772 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001628280-25-029773 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001628280-25-029774 | Jun 5, 2025 | Jun 4, 2025 |